Brainomix
Oxford, UK· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
AI-powered neuroimaging software for faster, more accurate stroke assessment and treatment decisions.
NeuroscienceStroke
Technology Platform
A proprietary AI engine that automates the quantification and interpretation of brain scans (CT and MRI) to identify biomarkers for acute neurological conditions.
Opportunities
Significant growth potential from global adoption of AI triage in stroke networks and expansion into new neurological indications.
Risk Factors
Regulatory hurdles in new markets and competition from larger, well-funded AI imaging companies could challenge market penetration.
Competitive Landscape
Competes with broad radiology AI platforms like Aidoc and Viz.ai, but maintains an edge through deep, stroke-specific algorithm validation and integration into clinical pathways.